GLP-1 receptor agonist in patients with type 2 diabetes has the effect of delaying gastric emptying, reducing the increase of superior mesenteric artery blood flow, and attenuating the decrease in postprandial blood pressure. Here, GLP1R is linked to type 2 diabetes mellitus.